Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|January 26, 2013
Improved discovery of molecular interactions in genome-scale data with adaptive model-based normalizationJulia Salzman, Daniel M Klass, Patrick O Brown
Plos One|September 17, 2010
Proteome-wide search reveals unexpected RNA-binding proteins in Saccharomyces cerevisiaeNikoleta G Tsvetanova, Daniel M Klass, Julia Salzman, et al.
Plos One|January 4, 2014
Whi3, an S. cerevisiae RNA-binding protein, is a component of stress granules that regulates levels of its target mRNAsKristen J Holmes, Daniel M Klass, Evan L Guiney, et al.
Genome Research|May 3, 2013
Quantitative proteomic analysis reveals concurrent RNA-protein interactions and identifies new RNA-binding proteins in Saccharomyces cerevisiaeDaniel M Klass, Marion Scheibe, Falk Butter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2019
ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Positive NSCLC: Pooled Analysis of Two Prospective TrialsJohannes Noé, Alex Lovejoy, Sai-Hong Ignatius Ou, et al.
The Journal of Molecular Diagnostics : JMD|April 1, 2022
Quantitative PCR-Based Method to Assess Cell-Free DNA Quality, Adjust Input Mass, and Improve Next-Generation Sequencing Assay PerformanceSeng Lor Saelee, Alexander F Lovejoy, Bernd Hinzmann, et al.
Nature Genetics|May 10, 2006
Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locusSusanne M Clee, Brian S Yandell, Kathryn M Schueler, et al.
Nature Biotechnology|March 29, 2016
Integrated digital error suppression for improved detection of circulating tumor DNAAaron M Newman, Alexander F Lovejoy, Daniel M Klass, et al.
Science Translational Medicine|November 11, 2016
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNAFlorian Scherer, David M Kurtz, Aaron M Newman, et al.
JCO Precision Oncology|August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint InhibitorsDiana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
Pageof 1